Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan

doi:10.4254/wjh.v8.i5.301

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10694)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-4) series.

Item

Count

PDF

1271

WORD

356

HTML

3850

Tables (1-4)

230

Sum=5707

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

478

Download

974

Sum=1452

Publishing Process of This Article

Item

Count

Browse

1267

Download

2268

Sum=3535

Feb 18, 2016 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Hepatol. Feb 18, 2016; 8(5): 301-306
Published online Feb 18, 2016. doi: 10.4254/wjh.v8.i5.301

Table 4 Multiple variables model for DNA methylation and hepatocellular carcinoma risk

Variable	OR (95%CI)	P
WNK2 cg10272601¹	2.26 (1.42-3.61)	0.0006
TPO cg12680131²	0.55 (0.34-0.87)	0.01
MYT1L cg22511877³	0.53 (0.32-0.88)	0.01
HBsAg (positive vs negative)	5.50 (3.34-9.03)	< 0.0001
Alcohol (yes vs no)	2.10 (1.08-4.07)	0.03

¹Above or below the median of 0.279;

²Above or below the median of 0.836;

³Above or below the median of 0.636. HBsAg: Hepatitis B virus surface antigen.

Citation: Wu HC, Shen J, Yang HI, Tsai WY, Chen CJ, Santella RM. Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan. World J Hepatol 2016; 8(5): 301-306
URL: https://www.wjgnet.com/1948-5182/full/v8/i5/301.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i5.301